According to profiling of matched tumors from individual patients, somatic TP53 alterations appeared early in localized tumors from patients who later had metastatic illness, indicating that the presence of TP53 alterations may predict the increased risk of progression to metastatic disease [50]. Here, TP53 is linked to metastatic neoplasm.